<span>Labcorp opens new Los Angeles based laboratory</span>
December 8, 2022

Labcorp opens new Los Angeles based laboratory

New Space Will Be Three Times Larger and Increase Testing Capabilities BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 8, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has begun operations at a new, larger anatomic pathology and histology (APH) laboratory in
<span>Labcorp first national laboratory to offer monkeypox test</span>
July 6, 2022

Labcorp first national laboratory to offer monkeypox test

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 6, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced it will begin testing for monkeypox using the U.S. Centers for Disease Control and Prevention’s ( CDC ) orthopoxvirus test, which detects all non-smallpox related orthopoxviruses, including monkeypox.
<span>Labcorp plans laboratory expansion in Japan through BML collaboration</span>
June 28, 2022

Labcorp plans laboratory expansion in Japan through BML collaboration

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 28, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it is enhancing its central laboratory presence and drug development capabilities in Japan through an expansion of CB Trial Laboratory, the central laboratory co-managed by Labcorp Drug Development and BML, a leading Japanese provider of clinical laboratory testing services.